美国 · 平台与数据 · Stocktwits
AstraZeneca Launches Targeted Lung Cancer Drug In US After FDA Accelerated Approval
AstraZeneca (AZN) shares drew investor attention on Thursday after the biopharmaceutical company announced the U.S. launch of its lung cancer drug Zegfrovy (Sunvozertinib).
在 Stocktwits 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (stocktwits.com)
